UiPath Inc. (NYSE:PATH) Receives $18.06 Consensus PT from Brokerages

UiPath Inc. (NYSE:PATH) has been assigned an average rating of “Hold” from the eighteen ratings firms that are currently covering the firm, Marketbeat.com reports. Sixteen investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $18.06.

PATH has been the subject of a number of recent analyst reports. DA Davidson lowered their price target on UiPath from $24.00 to $13.00 and set a “neutral” rating for the company in a research note on Thursday, May 30th. Barclays cut their target price on shares of UiPath from $25.00 to $16.00 and set an “equal weight” rating on the stock in a report on Thursday, May 30th. KeyCorp reissued a “sector weight” rating on shares of UiPath in a report on Thursday, May 30th. Needham & Company LLC reaffirmed a “hold” rating on shares of UiPath in a research note on Thursday, May 30th. Finally, BMO Capital Markets reduced their target price on UiPath from $28.00 to $14.00 and set a “market perform” rating on the stock in a report on Monday, June 3rd.

Insider Activity

In related news, CFO Ashim Gupta sold 40,000 shares of the firm’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $19.79, for a total value of $791,600.00. Following the completion of the transaction, the chief financial officer now owns 946,848 shares of the company’s stock, valued at $18,738,121.92. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 22.37% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Wellington Management Group LLP boosted its holdings in shares of UiPath by 59.0% in the 3rd quarter. Wellington Management Group LLP now owns 99,930 shares of the healthcare company’s stock valued at $1,710,000 after buying an additional 37,062 shares during the last quarter. Vanguard Group Inc. lifted its stake in UiPath by 7.6% in the 3rd quarter. Vanguard Group Inc. now owns 37,750,773 shares of the healthcare company’s stock valued at $645,916,000 after purchasing an additional 2,673,718 shares during the last quarter. Handelsinvest Investeringsforvaltning bought a new position in UiPath during the fourth quarter worth about $482,000. Gulf International Bank UK Ltd increased its position in UiPath by 111.8% during the fourth quarter. Gulf International Bank UK Ltd now owns 41,794 shares of the healthcare company’s stock worth $1,038,000 after buying an additional 22,061 shares during the last quarter. Finally, Archford Capital Strategies LLC raised its stake in UiPath by 18.1% in the fourth quarter. Archford Capital Strategies LLC now owns 23,154 shares of the healthcare company’s stock valued at $575,000 after buying an additional 3,550 shares during the period. 62.50% of the stock is owned by institutional investors and hedge funds.

UiPath Stock Performance

Shares of NYSE PATH opened at $11.93 on Thursday. UiPath has a fifty-two week low of $11.07 and a fifty-two week high of $27.87. The company’s 50 day simple moving average is $13.62 and its 200 day simple moving average is $19.23.

UiPath (NYSE:PATH) last posted its quarterly earnings results on Wednesday, May 29th. The healthcare company reported ($0.03) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.03). UiPath had a negative return on equity of 2.97% and a negative net margin of 6.41%. The company had revenue of $335.11 million for the quarter, compared to the consensus estimate of $332.84 million. On average, research analysts anticipate that UiPath will post -0.22 EPS for the current year.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.